Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1999 Jul 6;96(14):8098-103.
doi: 10.1073/pnas.96.14.8098.

Control of separate pathogenic autoantibody responses marks MHC gene contributions to murine lupus

Affiliations

Control of separate pathogenic autoantibody responses marks MHC gene contributions to murine lupus

T J Vyse et al. Proc Natl Acad Sci U S A. .

Abstract

Previous studies have suggested that MHC and non-MHC genes contribute to the development of autoimmune disease in F1 hybrids of New Zealand black (NZB) and white (NZW) mice. We conducted a genome-wide screen of 148 female (NZB x NZW)F1 x NZB backcross mice to map dominant NZW genetic loci linked with lupus disease traits. In this backcross analysis, inheritance of the NZW MHC (H2(d/z) vs. H2(d/d)) was strongly linked with the development of lupus nephritis (P approximately 1 x 10(-16)), increasing the risk of disease by over 30-fold. H2(d/z) was also linked with elevated serum levels of IgG autoantibodies to single-stranded DNA, double-stranded DNA, histones, and chromatin but not with anti-gp70 autoantibodies, measured as circulating gp70-anti-gp70 immune complexes. Non-MHC contributions from NZW seemed weak in comparison to MHC, although NZW loci on chromosomes 7 and 16 were noted to be suggestively linked with autoantibody production. Strikingly, H2(d/z) (compared with H2(d/d)) enhanced antinuclear antibodies in a coordinate fashion but did not affect anti-gp70 production in the current backcross. However, the opposite influence was noted for H2(d/z) (compared with H2(z/z)) when (NZB x NZW)F1 x NZW backcross mice were analyzed. These results suggest that H2(z) and H2(d) haplotypes differentially regulate two different sets of nephritogenic autoantibody responses. This study confirms a critical role for H2(z) compared with other dominant NZW loci in (NZB x NZW)F1 mice and provides an explanation as to why H2(d/z) heterozygosity is required for full expression of disease in this model.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Association of nephritis with genotypes at MHC and particular non-MHC loci in 148 (NZB × NZW)F1 × NZB backcross mice. The results are shown as percentage of mice with severe nephritis, which correlated closely with early mortality (11), in relation to the genotypes shown.
Figure 2
Figure 2
The pattern of linkage with nephritis (determined by χ2 analysis) as well as with IgG anti-dsDNA production and gp70 IC production (determined by mapmaker/qtl) in (NZB × NZW)F1 × NZB backcross mice is shown for loci on chromosome 7. There are two peaks of linkage: one at D7Nds5 (close to the position of Sle3; ref. 14) and a second at D7Mit148 (close to the position of Nba3; ref. 12). Data are derived from 148 mice followed for development of nephritis, of which 131 were studied for both anti-dsDNA and gp70 IC.
Figure 3
Figure 3
Selective effects of H2z in F1 × NZB backcross mice vs. H2d in F1 × NZW backcross mice. The data are presented as linkage values (MLS) for H2d/z vs. H2d/d in F1 × NZB backcross mice and for H2d/z vs. H2z/z in F1 × NZW backcross mice. MLS > 1.4, P < 0.01; MLS > 2.35, P < 1 × 10−3; MLS > 3.3, P <1 × 10−4; MLS > 4.23, P < 1 × 10−5. Data are derived from 148 F1 × NZB mice followed for nephritis, 131 F1 × NZB mice studied serologically, 108 F1 × NZW mice followed for nephritis, and 92 F1 × NZW mice studied serologically.

References

    1. Howie J B, Helyer B J. Adv Immunol. 1968;9:215–266. - PubMed
    1. Theofilopoulos A N. In: Systemic Lupus Erythematosus. Lahita R G, editor. New York: Churchill Livingstone; 1992. pp. 121–194.
    1. Kotzin B L. Cell. 1996;85:303–306. - PubMed
    1. Madaio M P, Carlson J, Cataldo J, Ucci A, Migliorini P, Pankewycz O. J Immunol. 1987;138:2883–2889. - PubMed
    1. Raz E, Brezis M, Rosenmann E, Eilat D. J Immunol. 1989;142:3076–3082. - PubMed

Publication types

MeSH terms